Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke

Stroke

Volumn 37, Issue 7, 2006, Pages 1686-1690

  Zee, Robert Y L ^a   Romero, Jose R ^a   Gould, Jessica L ^a   Ricupero, Dennis A ^a   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Genetics; Polymorphism; Risk factors

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK REDUCTION; AMINO ACID SUBSTITUTION; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; GENETICS; MIDDLE AGED; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHYSICIAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK; SMOKING; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; DNA MUTATIONAL ANALYSIS; DOUBLE-BLIND METHOD; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; MYOCARDIAL INFARCTION; PHYSICIANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, IMMUNOLOGIC; RISK; SMOKING; UNITED STATES;

EID: 33745955453     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000226994.93914.6c     Document Type: Article

References (17)

1. Cipollone F, Iezzi A, Fazia M, Zucchelli M, Pini B, Cuccurullo C, De Cesare D, De Blasis G, Muraro R, Bei R, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A. The receptor rage as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation. 2003;108:1070-1077.
2. Abel M, Ritthaler U, Zhang Y, Deng Y, Schmidt AM, Greten J, Sernau T, Wahl P, Andrassy K, Ritz E, et al. Expression of receptors for advanced glycosylated end-products in renal disease. Nephrol Dial Transplant. 1995;10:1662-1667.
3. Ritthaler U, Deng Y, Zhang Y, Greten J, Abel M, Sido B, Allenberg J, Otto G, Roth H, Bierhaus A, et al. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol. 1995;146:688-694.
4. Chavakis T, Bierhaus A, Nawroth PP. Rage (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect. 2004;6:1219-1225.
5. Pettersson-Fernholm K, Forsblom C, Hudson BI, Perola M, Grant PJ, Groop PH. The functional -374 t/a rage gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes. 2003;52:891-894.
6. Hudson BI, Stickland MH, Futers TS, Grant PJ. Effects of novel polymorphisms in the rage gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes. 2001;50:1505-1511.
7. Falcone C, Campo I, Emanuele E, Buzzi MP, Zorzetto M, Sbarsi I, Cuccia M. Relationship between the -374t/a rage gene polymorphism and angiographic coronary artery disease. Int J Mol Med. 2004;14:1061-1064.
8. Physician's Health Study. Aspirin and primary prevention of coronary heart disease. N Engl J Med. 1989;321:1825-1828.
9. Berger K, Kase CS, Buring JE. Interobserver agreement in the classification of stroke in the Physicians' Health Study. Stroke. 1996;27:238-242.
10. de Kok JB, Wiegerinck ET, Giesendorf BA, Swinkels DW. Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (mgb probes). Hum Mutat. 2002;19:554-559.
11. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics. 1995;29:311-322.
12. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978-989.
13. Wallenstein S, Hodge SE, Weston A. Logistic regression model for analyzing extended haplotype data. Genet Epidemiol. 1998;15:173-181.
14. Hudson BI, Bucciarelli LG, Wendt T, Sakaguchi T, Lalla E, Qu W, Lu Y, Lee L, Stern DM, Naka Y, Ramasamy R, Yan SD, Yan SF, D'Agati V, Schmidt AM. Blockade of receptor for advanced glycation end products: A new target for therapeutic intervention in diabetic complications and inflammatory disorders. Arch Biochem Biophys. 2003;419:80-88.
15. Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, Lalla E, Chitnis S, Monteiro J, Stickland MH, Bucciarelli LG, Moser B, Moxley G, Itescu S, Grant PJ, Gregersen PK, Stern DM, Schmidt AM. Rage and arthritis: The g82s polymorphism amplifies the inflammatory response. Genes Immun. 2002;3:123-135.
16. Johnson JA, Terra SG. Beta-adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics. Pharm Res. 2002;19:1779-1787.
17. Zee RY, Cook NR, Reynolds R, Cheng S, Ridker PM. Haplotype analysis of the beta2 adrenergic receptor gene and risk of myocardial infarction in humans. Genetics. 2005;169:1583-1587.